Boston Therapeutics, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Boston Therapeutics, Inc.
The health care industry has come a long way in the past 35 years, although in some areas very little has changed. Recently retired In Vivo editor Peter Charlish has seen most of the major developments, and in his final feature, he looks back at some of the big stories in a reporting career that began in the early 1980s.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Device financing dropped more than 40% to $714 million in Q1; Smith & Nephew’s $1.7 billion acquisition of ArthroCare overshadowed acquisitions. Diagnostics companies raised $568 million, a 34% increase over 2013’s final quarter; nonprofits provided assets to diagnostics firms in multiple licensing arrangements.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
- OTC, Consumer
- Other Names / Subsidiaries
- CureDM Group Holdings, LLC